27884160|t|The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells.
27884160|a|BACKGROUND: As a well-characterized key player in various signal transduction networks, extracellular-signal-regulated kinase (ERK1/2) has been widely implicated in the development of many malignancies. We previously found that Leucine-rich repeat containing 4 (LRRC4) was a tumor suppressor and a negative regulator of the ERK/MAPK pathway in glioma tumorigenesis. However, the precise molecular role of LRRC4 in ERK signal transmission is unclear. METHODS: The interaction between LRRC4 and ERK1/2 was assessed by co-immunoprecipitation and GST pull-down assays in vivo and in vitro. We also investigated the interaction of LRRC4 and ERK1/2 and the role of the D domain in ERK activation in glioma cells. RESULTS: Here, we showed that LRRC4 and ERK1/2 interact via the D domain and CD domain, respectively. Following EGF stimuli, the D domain of LRRC4 anchors ERK1/2 in the cytoplasm and abrogates ERK1/2 activation and nuclear translocation. In glioblastoma cells, ectopic LRRC4 expression competitively inhibited the interaction of endogenous mitogen-activated protein kinase (MEK) and ERK1/2. Mutation of the D domain decreased the LRRC4-mediated inhibition of MAPK signaling and its anti-proliferation and anti-invasion roles. CONCLUSIONS: Our results demonstrated that the D domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells. These findings identify a new mechanism underlying glioblastoma progression and suggest a novel therapeutic strategy by restoring the activity of LRRC4 to decrease MAPK cascade activation.
27884160	16	21	LRRC4	Gene	64101
27884160	30	36	ERK1/2	Gene	5595;5594
27884160	81	84	MEK	Gene	5609
27884160	85	88	ERK	Gene	5594
27884160	103	109	glioma	Disease	MESH:D005910
27884160	244	250	ERK1/2	Gene	5595;5594
27884160	306	318	malignancies	Disease	MESH:D009369
27884160	345	377	Leucine-rich repeat containing 4	Gene	64101
27884160	379	384	LRRC4	Gene	64101
27884160	392	397	tumor	Disease	MESH:D009369
27884160	441	444	ERK	Gene	5594
27884160	461	467	glioma	Disease	MESH:D005910
27884160	522	527	LRRC4	Gene	64101
27884160	531	534	ERK	Gene	5594
27884160	600	605	LRRC4	Gene	64101
27884160	610	616	ERK1/2	Gene	5595;5594
27884160	743	748	LRRC4	Gene	64101
27884160	753	759	ERK1/2	Gene	5595;5594
27884160	792	795	ERK	Gene	5594
27884160	810	816	glioma	Disease	MESH:D005910
27884160	854	859	LRRC4	Gene	64101
27884160	864	870	ERK1/2	Gene	5595;5594
27884160	936	939	EGF	Gene	1950
27884160	965	970	LRRC4	Gene	64101
27884160	979	985	ERK1/2	Gene	5595;5594
27884160	1017	1023	ERK1/2	Gene	5595;5594
27884160	1065	1077	glioblastoma	Disease	MESH:D005909
27884160	1093	1098	LRRC4	Gene	64101
27884160	1164	1196	mitogen-activated protein kinase	Gene	5609
27884160	1198	1201	MEK	Gene	5609
27884160	1207	1213	ERK1/2	Gene	5595;5594
27884160	1254	1259	LRRC4	Gene	64101
27884160	1409	1414	LRRC4	Gene	64101
27884160	1423	1429	ERK1/2	Gene	5595;5594
27884160	1474	1477	MEK	Gene	5609
27884160	1478	1481	ERK	Gene	5594
27884160	1496	1502	glioma	Disease	MESH:D005910
27884160	1561	1573	glioblastoma	Disease	MESH:D005909
27884160	1656	1661	LRRC4	Gene	64101
27884160	Association	MESH:D005909	64101
27884160	Association	MESH:D005910	5609
27884160	Negative_Correlation	5609	64101
27884160	Negative_Correlation	5595	64101
27884160	Association	MESH:D009369	5595
27884160	Negative_Correlation	MESH:D009369	64101
27884160	Association	1950	64101
27884160	Positive_Correlation	1950	5594
27884160	Association	MESH:D005909	5594
27884160	Association	MESH:D005910	64101
27884160	Positive_Correlation	1950	5595
27884160	Association	MESH:D005910	5594
27884160	Association	MESH:D005909	5609
27884160	Negative_Correlation	5594	64101

